AZD1152-HQPA

AZD1152-HQPA
Item number Size Datasheet Manual SDS Delivery time Quantity Price
LKT-A9714.1 1 mg -

3 - 8 business days*

156.00€
LKT-A9714.5 5 mg -

3 - 8 business days*

289.00€
LKT-A9714.10 10 mg -

3 - 8 business days*

469.00€
 
AZD1152 inhibits aurora kinases B and C (AurB, AurC), preventing mitotic spindle formation and... more
Product information "AZD1152-HQPA"
AZD1152 inhibits aurora kinases B and C (AurB, AurC), preventing mitotic spindle formation and proper completion of mitosis. This compound exhibits anticancer chemotherapeutic activity and is currently in clinical trials as a potential treatment for cancers with solid tumors. In acute myelogenous leukemia (AML) and acute lymphocytic leukemia (ALL) cells, AZD1152 induces apoptosis, inhibiting proliferation. AZD1152 also induces apoptosis in glioma cells, inhibiting proliferation in vitro and tumor growth in vivo.
Keywords: Barasertib, AZD1152
Supplier: LKT Laboratories
Supplier-Nr: A9714

Properties

Application: Aurora kinase B / C inhibitor
MW: 507.56 D
Purity: >98%
Format: Solid

Database Information

CAS : 722544-51-6| Matching products
KEGG ID : K11479 | Matching products

Handling & Safety

Storage: +20°C
Shipping: +20°C (International: +20°C)
Caution
Our products are for laboratory research use only: Not for administration to humans!
You will get a certificate here
or to request a certificate of analysis.
Read, write and discuss reviews... more
Customer review for "AZD1152-HQPA"
Write a review
or to review a product.
Viewed